Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Regulatory T cells in autoimmune neuroinflammation.
Neuromyelitis optica spectrum disorders without and with autoimmune diseases.
[Magnetic resonance imaging of the brain in the monitoring of immune therapy of multiple sclerosis].
microRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases.
Expression of DNA methylation genes in secondary progressive multiple sclerosis.
Can "dissemination" include the PNS in adults with acute disseminated encephalomyelitis?
Clinical Relevance of Serum Aquaporin-4 Antibody Levels in Neuromyelitis Optica.
Ethyl-eicosapentaenoic acid ameliorates the clinical course of experimental allergic encephalomyelitis induced in dark agouti rats.
Reducing clinical trial risk in multiple sclerosis.
Association of TIM-1 5383-5397ins/del and TIM-3 -1541C>T polymorphisms with multiple sclerosis in Isfahan population.
Optimization of Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy Evaluated by Grip Strength Measurement.
Clinical, radiographic characteristics and immunomodulating changes in neuromyelitis optica with extensive brain lesions.
Change in quality of life and predictors of change among patients with multiple sclerosis: a prospective cohort study.
Idiopathic acute transverse myelitis: outcome and conversion to multiple sclerosis in a large series.
Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution.
Interferon alpha association with neuromyelitis optica.
Matrine regulates glutamate-related excitotoxic factors in experimental autoimmune encephalomyelitis.
Relapse of neuromyelitis optica during pregnancy-Treatment options and literature review.
Presentation of multiple sclerosis with comorbid Huntington's disease.
Stem cell therapy in multiple sclerosis: a future perspective.
The Use of Agmatine Provides the New Insight in an Experimental Model of Multiple Sclerosis.
Collateral benefit: the comeback of MOG antibodies as a biomarker in neurological practice.
Protective effect of a germline, IL-17-neutralizing antibody in murine models of autoimmune inflammatory disease.
Nanovesicle-based platform for the electrophysiological monitoring of aquaporin-4 and the real-time detection of its antibody.
Emerging Roles of Pericytes in the Regulation of the Neurovascular Unit in Health and Disease.
Pages
« first
‹ previous
…
604
605
606
607
608
609
610
611
612
…
next ›
last »